BridgeBio Pharma Inc (BBIO)
26.50
+0.28
(+1.09%)
USD |
NASDAQ |
Dec 20, 16:00
26.49
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Liabilities (Quarterly): 1.883B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Cassava Sciences Inc | 57.11M |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Vertex Pharmaceuticals Inc | 6.609B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 664.98M |
| Shareholders Equity (Quarterly) | -1.230B |
| Debt to Equity Ratio | -1.398 |
| Current Ratio | 3.193 |
| Net Debt Paydown Yield | -0.00% |